[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_1341 

# __Lack of drugs and vaccines__

## Category to which it belongs

* [Limited capacity, high demand, waning effectiveness, distribution difficulties, and access disparities hinder efficient vaccination efforts.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_25.md)

## Closest similar item

* [Lack of vaccine or cure](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1733.md)
* [Lack of vaccines and agent-specific drugs](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1528.md)
* [Lack of knowledge about the virus, treatments, and vaccines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2879.md)
* [Lack of medication and vaccines for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1483.md)
* [Lack of immunity](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2731.md)
* [Lack of covid-19 vaccine](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2277.md)
* [Lack of effective drugs](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2684.md)
* [Lack of immunity in the population](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2685.md)
* [Lack of access to vaccination](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3142.md)
* [Demand for vaccine development](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_423.md)

## Description of the risk

No drugs or vaccines are available, overburdened health systems

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/pages/RiskHealth/PBN__RiskHealth_0.md)

## Is the risk affecting GBN scales

* [No](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Scale_0.md)

## Type of impact of the risk (according to ISO37100)

* [Governance, empowerment and engagement](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Purpose_6.md)

## Type of purpose of the risk (according to ISO37100)

* [Resilience](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Impact_2.md)

## Mitigations of this risk

* [Rely on community interventions, transparency, and public engagement](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1840.md)

## Name of the risk

Increased morbidity and mortality rates

## Stakeholders who can mitigate this risk

* [Global health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_857.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Articles mentionning the risk

* [Covid-19 and community mitigation strategies in a pandemic](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_112.md)

## People affected by this risk

* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)

## Technologies linked to the risk

* [Research and development of drugs and vaccines](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_543.md)

## Property: has_RiskType

* [Technological](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_5.md)

